NCT04856631 2022-12-19A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell CancerShanghai Junshi Bioscience Co., Ltd.Phase 1/2 Unknown88 enrolled